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Abstract
This chapter outlines the clinical approaches for alopecic patients that are reliable 
in  practice. We discuss three different categories of hair evaluation options: invasive 
 methods (biopsy), semi-invasive methods (trichogram) and noninvasive methods. 
Besides describing the current status of diagnosis and quantification of alopecia, the 
chapter provides an objective assessment of these investigation tools: detailed medical 
history collection by structured interview and questionnaires, clinical examination of 
the scalp and other hair-bearing areas, laboratory investigations, assessment of hair loss 
distribution (patterned/diffuse/focal), dermoscopic evaluation, assessment of alopecia 
severity (by pull test, hair part width, counting hair test), common scales for hair loss 
staging, photography of alopecic areas, biopsy, trichogram, unit area trichogram, tug 
test, hair mount and microscopic evaluation, electron microscopy, hair card test, hair 
weight determination, hair densitometry, mechanical test of hair quality and computed 
hair analysis. Unfortunately, the disadvantages of most of these methods generate a lack 
of use in clinical practice, leading to few reliable evaluation methods for patients suf-
fering from alopecia. We underline the necessity of easy, refined and precise evaluation 
tools for the assessment of alopecia patients.
Keywords: alopecia, hair loss, hair shedding, hair thinning, androgenetic alopecia, 
female pattern hair loss, telogen effluvium, anagen effluvium, alopecia areata, 
trichotillomania, tinea capitis, traction alopecia, evaluation methods, dermoscopy/
trichoscopy, pull test, counting hair tests, trichogram, microscopic evaluation, 
hair weight determination, hair densitometry, computed hair analysis
1. Introduction
Hair loss and hair thinning represent frequent complaints of both female and male patients in 
clinical dermatology. Establishing a correct management can be challenging, beginning from 
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the subjective description provided by the patient, the confirmation of a true hair disorder 
and its underlying pathogenesis.
Current literature describes a long list of evaluation methods for patients suffering of  alopecia. 
The objective assessment of these methods enable us to outline the clinical approaches 
that are reliable in practice. There are three different categories of hair evaluation options: 
invasive methods (biopsy), semi-invasive methods (trichogram) and noninvasive methods 
(interview with detailed medical history collection and questionnaires, systemic evaluation 
through laboratory tests and other investigations, counting hair tests, hair pull test and tug 
test, hair weight determination, densitometry or HairCheck test, imaging tests such as global 
photographs, trichoscopy, phototrichogram, videodermoscopy, light microscopy, etc.) [1–3]. 
All these assessment methods have merits and demerits, but for some, the disadvantages 
generate a lack of use in clinical practice [4]. Also the patients seem to be more interested in 
performing only some of them, especially the non-invasive methods.
The diagnosis of androgenetic alopecia or female pattern hair loss is confirmed clinically and 
extra tests are not usually required. The dermatologist focuses on detailed medical history 
and physical examination, analyzing the scalp aspect, the hair loss pattern, the trichoscopic 
findings and sometimes the pull test results [5]. Basic hair evaluation methods also include 
scalp biopsy (each alopecia having a specific histopathological aspect), but this invasive 
method is only sometimes necessary for establishing a diagnosis [3, 6].
2. Detailed medical history
Collecting information is of main importance and can be done by carefully listening to the 
patients on the following subjects:
a. date/age of onset (congenital or acquired),
b. type of onset (sudden or insidious), correlated with other medical issues or personal 
events. Chronic or acute stress, for example, lowers the production of estrogens, leaving 
the genetically targeted hair follicles susceptible to testosterone action and inducing hair 
loss by premature onset of catagen [7].
c. physiological changes, such as childbirth (1–3 months after delivery hair follicles revert to 
telogen and begin to fall out as a new growth cycle of hair begins) [3, 8]. While  breastfeeding 
prolactin can delay hair loss. Miscarriage or termination also lead to significant hair loss, 
especially after the first 3 months of pregnancy. In babies, alopecia is physiological up to 
6 months due to a decrease of hormones after birth that will induce telogen effluvium. 
Finally, gradual thinning and finer textured hair are common with aging (involutional 
alopecia) and around menopause [9].
d. illnesses and infections prior to the onset of alopecia, or other possible trigger factors 
in the previous 2–5 months (high fever, chronic blood loss in women with prolonged 
heavy menses (anemia) or severe dietary protein deficiency, as they correlate with chronic 
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telogen effluvium (CTE) [7, 9]. Finding out if the patient follows a certain diet is also 
important to establish if the protein and calories intake is adequate. Anemia (lack of iron 
and low ferritin levels) may lead to diffuse hair thinning everywhere on the scalp, changes 
of hair texture (brittle hair) and strands breaking off in different lengths [9]. Sometimes an 
episode of telogen effluvium may uncover a latent AGA [8].
e. past medical history (chronic illnesses, surgeries, autoimmune, dermatologic and psychiatric 
disorders, etc.). The dermatologist should identify if other dermatological or endocrino-
logical diseases are present, and if so, they must be properly investigated and treated. 
Atopy, autoimmune thyroid disease and vitiligo are commonly associated with alopecia 
areata [10]. Female pattern hair loss is common in patients with polycystic ovary syndrome 
(PCOS – with clinical signs: acne, increased facial hair as part of hirsutism, irregular peri-
ods, infertility, weight gain), congenital adrenal hyperplasia (an adrenal tumor causes a 
conversion of the hormones normally produced, increasing the testosterone levels), etc. 
[11, 12].
f. medication used by the patient, as some of them may induce hair loss: anticancer drugs, 
anticoagulants, anticonvulsants, antithyroid drugs, beta blockers, tricyclic  antidepressants, 
and progestins with androgenic effects [7]. The contraceptive pills can act as treatment or 
cause of hair loss: in the first 3 months of use they determine either thicker hair regrowth or 
increased fall rate, especially after discontinuation [11]. Contraceptive pills with a high level 
of progestins may lead to hair loss, together with acne and hirsutism, and if so, they need 
to be switched to pills based on ethinoestradiol [9]. Anagen effluvium secondary to drugs is 
usually caused by cancer chemotherapy and immunotherapy drugs, having a more diffuse 
and rapid progression than telogen effluvium [13].
g. rate of progression, if it has any season pattern. If the patient has noticed hair regrowth 
since the onset of alopecia, this rules out cicatricial alopecia. The duration and extent of the 
hair loss process is important for the prognosis. Early, long-lasting and severe cases of alo-
pecia areata have a less favorable prognosis, but no correlation has been found between the 
number of patches at onset and the subsequent severity of the disease [10]. Frontal fibros-
ing alopecia has an unpredictable evolution, and as well as central centrifugal cicatricial 
alopecia, if not treated, will burn out [6]. The prognosis in androgenetic alopecia and 
female pattern hair loss depends on the treatment: once discontinued the hair regrowth 
will be lost in 6–12 months and the hair pattern will return to the baseline state [14, 15]. In 
FPHL patients, complete hair loss on the central scalp is rare, in contrast to male-pattern 
baldness. Chronic effluvium telogen is usually a self-limiting condition, lasting more than 
6 months, while anagen effluvium is entirely reversible, with hair regrowth after 6 months 
[7]. Scarring (cicatricial) hair loss tends to have a generally unfavorable prognosis.
h. associated symptoms such as: itching, tenderness, pain, burning sensation. It has been 
reported that 14% of the patients suffering of alopecia areata suffer a burning sensation 
and accentuated pruritus [10].
i. type of treatment (topic solutions, pills, laser, etc.) patients have used and the result from 
their point of view. Also focus on how the patient treats their hair on a daily/monthly 
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basis with: chemical agents (dying, coloring, etc.), thermic agents (heat from hair curler 
or straightener, etc.), hair cosmetics (dry shampoo, hair stimulating shampoo, balm, hair 
tonic, hairspray, gel, mousse or topical camouflaging fibers, etc.) and their frequency of 
use [11, 16].
j. the family history of alopecia, autoimmune, dermatologic or psychiatric disorders [17]. 
Androgenetic alopecia or alopecia areata may exist in the family, but cicatricial alopecias 
rarely occur in family members (except Central Centrifugal Cicatricial Alopecia). In a personal 
study, 57% of the patients with female pattern hair loss had a positive family history: the 
mother in 29% of the cases, the father in 21% of the situations [16].
k. race of the patient is also important. For example, central centrifugal cicatricial alopecia 
occurs in black women, resembling lichen planopilaris [6]. Dissecting cellulitis of the scalp 
is frequent mostly in black adolescents and adult males.
l. different types of alopecia that may sometimes coexist: alopecia areata with trichotillomania 
[18], both patchy and diffuse alopecia areata with androgenetic alopecia (AGA) [8, 13], female 
pattern hair loss (FPHL) with frontal fibrosing alopecia (FAA) [19].
2.1. Structured interview: standardized flowchart
A standardized chart represents an easy evaluation tool for the patient’s course over time, so 
no data will be omitted or forgotten. It collects important information at each patient visit, 
providing a good overview and it is also a helpful reminder of all the items of interest, helping 
the dermatologist to pass through all necessary tests. The flow chart can contain the  symptoms 
of the patients, the clinical sign, the dermoscopy findings, the pull and tug tests results, the 
extent of hair loss, laboratory results, biopsy results, treatments performed, etc. [6]. One can 
use a standard flow chart already published and applied in clinical practice or design a new 
chart that suits his own needs.
2.2. Questionnaires
Several questionnaires have been used so far for hair loss patients to assess the quality of life 
and associated lifestyle patterns. One study used the Hairdex, lifestyle indexes, Symptom 
check list 90R and output psychiatric rating scales, but the major complaint of the patients 
when completing the survey was that all together, the 4 questionnaires contained more than 
120 questions, which was both time consuming and tiring [20]. In a personal research we 
developed and used for FPHL patients a new questionnaire, more concise (26 questions), time 
effective (30 min) and full of relevant information [20]. Our questionnaire collected data upon 
demographic items (race, age, level of education, urban/county environment), illness-specific 
data (patients complaint, status of scalp visibility/severity of disease, duration of hair loss, 
type of hair), risk factors (family history of alopecia, scalp diseases, possible cause of hair 
fall, cosmetic products and devices used on hair, covering of hair with products or items), 
psychosocial consequences (affected self-confidence, affected mood, how often they think of 
hair loss, what aspects of life are disturbed by alopecia), treatment (prescribed by doctor, 
therapy already performed, therapy the patient would like to perform, the main purpose for 
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the treatment in patients opinion), and last but not least the evaluation of the questionnaire 
(useful and easy to complete) [14].
Questionnaires of hair loss are available online (for printing or online completion) on the 
websites of different clinical practice offices and need to be completed before the first visit. 
The majority of the questionnaires refer to diffuse shedding or thinning, but some also have 
a hair loss in patches section. Ranging from 22 to 35 questions, they gather information about 
the background of hair loss, past medical history, diet and medication history, hair care 
practices.
Even though questionnaires seem to please the patients and to gather a large volume of 
 information in a short period of time, some of the subjects do complain that it is a more distant 
kind of approach and that they lack the interaction with the doctor.
3. Clinical examination
For alopecic patients, the clinical examination begins as soon as they enter the doctor’s office 
as you can notice right away if the scalp is visible across the room, if hair thinning is present 
[6]. For most of the cases you can assess from the first glimpse the extent of alopecia: localized 
or diffuse.
Pay attention to the patient’s hair style, as it might try to hide the alopecic areas, but also 
gives you hints about how the patient treats the hair, underlying possible risk factors [5, 17]. 
Ask the patients if they use back combing, hair curling wand or hair straightener, decolorizer, 
hair dye, or mechanic aggression. Overuse of heat and chemical treatments leads to hair shaft 
damage and hair loss, also to an increased tendency to develop traction alopecia [21]. Patients 
with traction alopecia usually wear their hair in positions which induce prolonged and 
 repetitive tension on the hair (for example pony tails or braids) [6]. The presence of retained 
hairs along the frontal and/or temporal rim, is called the “fringe sign” and is a useful clinical 
marker present in both early and late traction alopecia [22].
The evaluation of an alopecic patient should include the examination of other hair-bearing 
sites besides the scalp in order to determine if hair loss is present in: eyebrows, eyelashes, 
limbs, axillae or pubic area [23]. The examination of the skin, nails, oral or genital mucous 
membranes is also needed (for evidence of associated dermatoses, such as lichen planus) 
[3, 11, 24].
After a thorough clinical examination in order to evaluate impaired vision, defective hearing, 
dysmorphic features, clues to autoimmune or metabolic diseases, or ectodermal anomalies, the 
dermatologist should rule out if the patient has a condition defined by sparse hair (autosomal 
recessive hypotrichosis—wooly, easily broken hair) or loss of hair (alopecia). Then decide what 
type of alopecia it is: localized or diffuse, scarring or non-scarring [25].
In order to establish a diagnosis, the doctor will inspect the scalp for inflammation, scaling, 
erythema, follicular openings, then examine the pattern distribution and determine the hair 
density, finally study the caliber, fragility, length and shape of hair shaft [2, 23].




For clinical examination, the patient must remove hair pieces, pins, clips, braids, hair 
 extensions and preferably sit on a chair than on the examination table [6]. Good lighting 
is  essential, when pictures are taken [6, 11]. The dermatologist must examine the hair and 
scalp from above, then proceed with a magnifying light or dermatoscope for trichoscopic 
 assessment. A thorough examination requires a serial parting of the hair starting at the center 
of the scalp, with fingertips, disposable combs or the wooden end of a Q-tip [6].
If during the clinical exam, diminished or absent follicular ostia is noticed, a diagnosis of 
cicatricial alopecia is most likely positive and the detailed history of the patient should be 
guided in this direction [6]. In patients with darkly pigmented skin, in which it is difficult cu 
appreciate the follicular ostia, it is recommended to perform the skin biopsy.
The area with hair loss must be examined closely to determine whether it is bare as “as baby’s 
bottom” (characteristic of alopecia areata) or it maintains residual hairs or fine textured and 
miniaturized hairs, as in AGA [13, 22].
The color of the affected scalp is also important (pink, peach-colored or skin colored, with 
hypo- or hyperpigmentation, with telangiectasias, with erythema present perifollicular or in 
patches, etc.).
The scalp must be examined for signs of atrophy or scaling (perifollicular or in patches), for 
edema, papules, pustules, crusts, follicular hyperkeratosis, ulceration and scarring [22, 24].
Atrophy, loss of follicular openings and tufted hair are usually present in scarring hair loss (in 
non-scarring hair loss they are absent), while erythema, scaling or pustules may be present 
in both types of alopecia. An almost normal scalp skin with a pale, shiny or mildly scarred 
aspect is present in frontal fibrosing alopecia, a form of lichen planopilaris [19, 21].
Most of the time, patients leave their hair unwashed and uncombed for the doctors’ appointment 
to show how oily it is or how much hair falls down when combing [5, 11]. In a personal study 
we have reported that 68% of the patients suffering of female pattern hair loss presented also 
hyperseborrhea and 7% had seborrheic dermatitis with annoying pruritus [14].
Hyperseborrhea is the hyperactivity of sebaceous glands leading to an excessive  production 
of sebum with immediate symptoms such as itchiness and pain. Hormonal imbalances, 
metabolic disorders (nutrition and elimination), digestive problems (hepatic and intestinal 
dysfunctions), nervous factors and stress favor its appearance. Hyperseborrhea may lead to: 
hair loss, accelerated skin whitening, oily hair, hair blemishes and deterioration, bad-smelling 
skin, folliculitis, acne, pityriasis steatoides, seborrheic dermatitis [11, 13].
Seborrheic dermatitis is not infectious, but it involves the proliferation of yeast normally  present 
on one’s skin (malassezia yeast being lipophilic, the sebum becomes a source of food). The 
sebum usually represents a scalp protection barrier with antibacterial and  antidehydration 
property, that moisturizes, protects and waterproofs the hair shaft. Seborrheic dermatitis 
may non-specifically cause diffuse hair loss as hair follicles find an unsuitable development 
 environment in inflamed skin which will generate a shorter anagen [24].
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3.2. Pattern or distribution of hair loss assessment
By analyzing the extent, pattern or distribution of hair loss (focal patchy, patchy all over, diffuse, 
central, intact frontal hairline, loss of hair in the eyebrows, eyelashes, limbs, axillae, pubic area, 
etc.) the dermatologist can rule out some diseases in the differential diagnosis process.
3.2.1. Diseases with patterned hair loss
There are some hair loss conditions which seem to affect a certain part of the scalp. For 
 example, androgenetic alopecia (AGA) has an early age of onset with an “M shaped” hair 
thinning over the frontal area and parietal scalp, but conserving a greater density in the 
occipital scalp [11, 13, 14, 20] (Figure 1).
In the female pattern hair loss (FPHL) there is a “Christmas tree” progression of hair loss 
(central thinning) or it can happen in a diffuse manner, but with the retention of the frontal 
hairline [3, 16]. Advance thinning occurs in the frontal hairline and above the ears, when 
markedly elevated circulating androgens are present [5, 26]. The dermatologist must check 
if clinical signs and symptoms of androgen are present (menstrual irregularities, infertility, 
hirsutism, severe cystic acne, virilization, galactorrhea) [25]. Common complaints in females 
might be that the hair does not grow in length any more or that the pony tail is smaller in 
girth [8]. The clinical diagnosis of AGA and FPHL is supported by the pattern of hair thinning, 
the presence of miniaturized hairs (increased spacing between hairs, shorter and fine hairs of 
various lengths and diameters) and usually lack of increased shedding [8, 9, 11] (Figure 2).
AGA and FPHL are mostly seen as hair thinning conditions above the ears, sometimes 
extending posteriorly to the occipital hairline [27]. Another affected area is at the nape of the 
patients (back of the scalp) and possible causes are: the ‘ophiasis’ form of alopecia areata, 
Frontal fibrosing alopecia with hair loss starting as a band-like distribution around the frontal 
hairline but also at the sides, just behind the ears, Monilethrix (abnormality in how the hair 
shaft is produced, leading to hair breakage), overuse of heat and chemical treatments leading 
to hair shaft damage and hair loss at the nape [20, 21].
Figure 1. Male pattern suffering of androgenetic alopecia (AGA), grading on Hamilton-Norwood scale: (a) grade II 
lateral view; (b) grade II view from above scalp; (c) grade VI lateral view; and (d) grade VI view from above.
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The “moth-eaten” pattern of hair loss is the most common type and it is considered to be a 
pathognomonic manifestation of secondary syphilis [28]. Still, in some cases, alopecia can 
be the only presenting feature of syphilis, without any other clinical feature such as roseola 
syphilitica, mucous patches, condylomata lata, and ophthalmologic or auditory findings. 
Differential diagnosis is hard when the hair loss is not just moth-eaten, it is diffuse or both. 
Syphilitic alopecia can mimic alopecia areata both clinically and histopathologically, with 
lack of “exclamation point” hairs, characteristic of alopecia areata. Syphilitic alopecia can 
resemble a noninflammatory Tinea capitis, but laboratory testing of scrapings will indicate 
the presence of fungus. Trichotillomania can also be suspected, but it would be confirmed by 
history and findings of a biopsy [28].
3.2.2. Diseases with diffuse hair loss
Chronic telogen effluvium (CTE) affects women in the fourth to sixth decade, with a  sudden 
onset (frequently related to physiologic and emotional stress) of marked shedding of telogen 
hairs (which sometimes is prolonged) from the entire scalp, yet scalp hair density appears 
normal or minimally decreased. The dermatologist will not see miniaturized follicles at 
examination [9]. Anagen effluvium occurs days to weeks after chemotherapy in 65% of the 
cases and the hair loss is reversible [11, 13] (Figure 3).
Figure 2. Female pattern hair loss, grading on Ludwig scale: (a) grade I, (b) grade II, and (c) grade III.
Figure 3. Female patient suffering of telogen effluvium: (a) clinical view and (b) patient brought a small plastic bag full 
of the hair collected during the standardized wash test.
Alopecia8
DUPA or diffuse unpatterned alopecia in males is characterized by hair thinning on the top 
(without progression to complete baldness) and diffuse miniaturization throughout the 
occipital area also, being a contraindication for hair transplant [23].
Alopecia areata can affect any hair-bearing area, being described as alopecia totalis (scalp hair 
loss), or universal (loss of all hairs from body and scalp, including eyebrows, eyelashes, etc.) [10].
Induced metabolic disorders lead to diffuse hair loss [11].
The presence of alopecia in infants and children may be due to congenital or acquired causes. 
Congenital diffuse hair loss could consist of congenital hypotrichosis/atrichia or hair shaft 
anomalies, such as Nethersons (bamboo hair, atrophy), Menkes (beaded hair) or Monilethrix 
(wiry hair, pale skin, pili torti). Acquired diffuse hair loss in children occurs in history of 
prolonged illness (telogen effluvium) or exposure to radio/chemotherapy (anagen effluvium). 
Medical conditions such as thyroid disorders or hyperpituitarism can also cause diffuse hair 
loss [29, 30].
3.2.3. Diseases with focal hair loss
Alopecia areata most often affects the scalp and is described as acute circumscribed hair loss 
(80% of the patients having just a single patch). The clinical diagnosis is made by the aspect of 
hairless patches with a normal skin and preserved follicular ostia [10] (Figure 4).
Tinea capitis represents a dermatophyte infection of the hair shaft and follicles, leading to 
fragile and easily broken hair [13, 24].
Trichotillomania is a type of alopecia with irregular patches, determined by the patient who 
twirls or pulls his hair compulsively. Patches occur especially frontoparietal, progressing 
backward and may include eyelashes and eyebrows, being described as incomplete thinning 
with stubble [8, 23].
Figure 4. Female patient suffering of alopecia areata (AA), having: (a) a single AA patch and (b) multiple, confluent AA 
patches.
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Traction alopecia refers to frontal and temporal loss of hair. Not only some hair styles 
cause traction alopecia, but also facelifts, due to the tightening and trimming of the skin. 
The  dermatologist must distinguish traction hair loss from hair loss recession due to frontal 
fibrosing alopecia or alopecia areata [3, 24].
Primary cicatricial alopecias have many subtypes mostly presenting patchy hair loss and 
some of them cellulitis or folliculitis. The clinical features of lichen planopilaris are itchy, 
 multifocal or central patches on scalp and nonscalp areas with follicular hyperkeratosis and 
perifollicular erythema. Chronic cutaneous lupus erythematosus presents single or  multifocal 
patches with intense activity in the patch center, ulceration, follicular plugging, atrophy and 
 depigmentation. Brocq pseudopelade consists of small or large irregular patches on the scalp 
with no  detectable symptoms or inflammation, with end-stage burnout. Clinically folliculitis 
decalvans is described as a single patch of complete alopecia on the hair-bearing periphery 
of the scalp (it expands  circumferentially, slowly over the years) and pustules, honey-colored 
crusting and tufting. Dissecting cellulitis of the scalp presents multiple fluctuant nodules 
across the scalp,  interconnected by sinus tracts and sometimes patients also suffer from acne 
conglobate [6, 29].
The congenital focal hair loss in infants and children may be due to traumatic events (birth 
trauma) or nevoid conditions, such as velvety smooth (nevus sebaceous), warty (epidermal 
nevus) or absent overlying skin (aplasia cutis). Acquired focal hair loss in children occurs in 
trichotillomania (with irregularly broken hair due to mechanic repetitive traction performed 
by the child itself), tinea capitis or ringworm (fungal infection which leads to patchy bald 
spots with red, flaky scaling, easy pluckability of hairs and cervical lymphadenopathy) or 
alopecia areata (smooth, round, totally bald areas with the detection of exclamation point hair 
in trichoscopy and nail pits). Even traction alopecia (from tight ponytails) can result in focal 
hair loss [30, 31].
3.3. Dermoscopy
Trichoscopy represents the dermoscopy imaging of the scalp and hair. Pigmented patterns 
must be assessed by dermatoscope with an interface solution, while interfollicular patterns 
are visualized only with a polarizing light source (or filter) or a videodermoscope, as direct 
contact can produce bleaching [32–34].
Trichoscopic evaluation of the scalp is based on the observation of follicular patterns 
(white dots—destroyed follicles that are replaced by fibrous tracts, yellow dots—follicular 
 infundibulum with degenerating keratinocytes and sebum, black dots—stubs of cadaverized 
hair, fractured before emerging from the scalp), interfollicular patterns (pigment pattern and 
vascular pattern with interfollicular simple red loops or twisted loops or arborizing red lines) 
and hair shaft characteristics (specific features in various genetic and inflammatory disorders) 
[35–37].
The assessment of the scalp must begin with the observation of the follicles presence, 
 suggesting a noncicatricial disease. Afterwards, the examiner must identify if yellow dots are 
present and if so, focus on the hair diameter.
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AGA trichoscopic characteristics are: hair shaft diameter variation of more than 20% hair 
shaft (miniaturization), peripilar halo in early stages, predominance of follicles bearing 
single hair, hypertrophy of sebaceous glands [11]. In severe AGA cases trichoscopy shows 
the  presence of empty follicular ostia, brown dots and honeycomb-like pigmented network 
in bald,  sun-exposed areas [38]. The latest reports indicate that although miniaturization of 
hairs (progressive thinning of hairs) is a specific feature of AGA and FPHL, it is also found in 
alopecia areata and traction alopecia cases [39].
For FPHL, a study suggests that 2 major criteria (more than 4 yellow dots in a field of view in 
frontal area/a lower mean hair thickness in frontal area/more than 10% thin hairs <0.03 mm in 
frontal area) or one major and two minor criteria (ratio of single-hair units, frontal area to occiput 
>2:1/ ratio of vellus hairs frontal area to occiput>1.5:1/ratio of hair follicles with perifollicular discol-
oration frontal area to occiput>3:1) are necessary for a trichoscopic diagnosis with a 98% specificity 
[40]. Previously, FPHL has been diagnosed on two dermoscopic criteria: more than 20% variability 
in hair shaft diameter and more than 7 short regrowing hairs in the frontal scalp [11, 41] (Figure 5).
The dermatologist must identify if black dots are present, which is suggestive for AA, 
 trichotillomania or tinea capitis (black dots tinea).
In trichoscopy, AA presents: yellow dots with short vellus hairs or empty follicles, dystrophic 
and tapered hairs and black dots representing cadaverized broken hairs. The trichogram may 
show dystrophic fractured and telogen roots [36] (Figure 6).
Trichotillomania is usually recognized by: curled hairs with hair shafts of variable length, 
longitudinal splitting of hair shafts and coiled fractured hair shafts. New trichoscopy findings 
that seem to be specific features of trichotillomania are: flame hairs, the V-sign, hook hairs, 
hair powder and tulip hairs [42].
Telogen effluvium is a diagnosis of exclusion as it is described by decreased hair density and 
presence of empty follicles. It is differentiated from AGA due to the absence of a certain site 
predilection, hair shaft diameter variation or peripilar halo [32].
Figure 5. Trichoscopy of (a) AGA patient (hair miniaturization with diameter diversity >20%, thin hair, predominance 
of follicles bearing single hair, peripilar halo, yellow dots, vellus regrowing hair) b) AA patient (exclamation marks, 
cadaverized hairs-black dots, yellow dots) (DermLite DL100).
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If the trichoscopic assessment of the scalp does not reveal the presence of the follicles, but 
milky-red or ivory-white areas lacking follicular openings, the dermatologist must think of 
forms of cicatricial alopecia.
Dissecting cellulitis characteristic findings are: “3D” yellow dots imposed over dystrophic 
hairs, large, yellow amorphous areas and pinpoint white dots with a whitish halo [7]. Early 
stages of the disease may mimic AA findings, while the exclamation mark hairs and white 
dots are markers of disease chronicity [43, 44].
Trichoscopy features in Tinea capitis are: comma shaped stubs/hairs, black dots tinea (stub 
of broken hair shafts with scaling), blotchy pigmentation, erythema, scaling, pustules and 
follicular scale-crust formation. It has fluorescence in UV examination [32].
Figure 6. Trichoscopic aspect of (a) chronic AA patient (keratotic plugs in the follicular openings) and (b) hair dye on the 
scalp surface in an AA female patient (dye is within the follicular openings, simulating interfollicular hyperpigmentation 
and dots) (DermLite DL100).
Figure 7. Trichoscopy of: (a) normal scalp, patient without alopecia and (b) patient with lichen planopilaris (peripilar 
scale, reduced hair density, erythema) (DermLite DL100).
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Lichen planopilaris (LPP) can be identified by: peripilar casts, target pattern “blue-gray dots”, 
spared intervening follicles, white dots. Trichogram examination may show anagen roots [45] 
(Figure 7).
The most characteristic trichoscopy features in Discoid lupus erythematosus (DLE) of the 
scalp are thick arborizing vessels and large yellow dots, atrophy, complete follicular paucity/
plugs, hyperkeratotic scales and dark brown pigmentation. A good prognostic factor of hair 
regrowth is represented by the presence of Red dots, difficult to be observed in brown skin 
color patients [46] (Figure 8).
Hair shaft disorders have a particular aspect: beaded shaft in monilethrix, brush fractures in 
trichorrhexis nodosa, shaft nodes in trichorrhexis invaginata, twisted shafts in pili torti [35, 47, 48].
Advantages of trichoscopy: it represents a handy and reliable tool for establishing a diagnosis, 
it allows a rapid examination of different areas of the scalp, easy capturing of photographs for 
documentation and comparison with pre-treatment images [33, 36, 38]. The disadvantages are that 
the examiner needs to acquire the skill and expertise necessary for a correct interpretation, to take 
into account the race (trichoscopy of vascular patterns is difficult in darker populations) and the 
shampooing habits of the patient (yellow dots may not be present in freshly washed scalp) [32, 49].
3.4. Videodermoscopy
Videodermoscopy represents a noninvasive tool for the observation of the scalp skin and 
hair, being a useful tool in the evaluation of hair loss, both for differential diagnosis and for 
prognostic evaluation [34, 50].
The videodermoscopy devices have the ability to capture digital images in a high resolution 
(magnification available up to 1000×) and to store them for later comparison. It is an adjuvant 
of trichoscopy and a prior step to performing a biopsy, also helping the dermatologist decide 
which is the right place to take the skin sample from [50].
Figure 8. Trichoscopic aspect of (a) discoid lupus erythematosus (arborizing vessels with red lines and dots, large yellow 
dots) and (b) pigtail hair in an AGA patient (DermLite DL100).
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4. Assessment of severity
4.1. The pull test
The dermatologist should briefly describe the method to the patient and tell him that the 
hair will be gently pulled several times. The technique will be repeated in different parts of 
the scalp: at a margin of a hair loss patch (in alopecia areata or trichotillomania) to see if it is 
active and in an unaffected scalp area to see if there is pendant activity, if the new grown hairs 
are stable [3, 5]. In diffuse telogen effluvium, androgenetic alopecia and female pattern hair 
loss, the two sites that are examined are: frontal (2 cm behind the forehead and lateral) and 
occipital (2 cm lateral from the occipital protuberance) [51].
Using the thumb and forefinger, the dermatologist will grasp a small section of hair (about 60 
strands) close to the scalp and gently but firmly slide the fingers away from the scalp at a 90° 
angle along the entire length of the hair swatch (Figure 9). The number of extracted hairs is 
counted [11]. If 6 more than 10% of the hair strands fall at the test, it means that the patient has 
an active hair loss, with one of the following differential diagnosis: telogen effluvium, anagen 
effluvium, loose anagen syndrome (common in young children), early androgenetic alopecia 
or female pattern hair loss or advanced alopecia areata. Also, it is important to establish what 
type of bulb do the extracted hairs present: anagen bulbs or telogen bulbs. Anagen bulb hairs 
Figure 9. (a) The pull test and (b) the tug test.
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are not usually pulled easily out of the scalp, but they may be extracted in a pull test in the 
 following situations: active primary cicatricial (scaring) alopecia, loose anagen syndrome or 
anagen arrest during chemotherapy [6]. An active phase of CTE would show a positive test 
with 6–8 telogen roots in light microscopy, while a loose anagen syndrome would  present 
a highly positive pull test with anagen hair roots mostly lacking the hair sheath (anagen 
 dysplastic) [37]. In Alopecia areata, after a positive pull test, a light microscopy assessment 
would show dystrophic anagen and telogen stage. In active AGA, the examiner can find a 
positive test in vertex and negative in the occipital area. In the active phase of anagen or 
 telogen effluvium an increased number of anagen or anagen dysplastic hairs or normal 
 telogen hairs would fall. Trichotillomania patients have a negative pull test.
The pull test has several disadvantages, being a rough and no standardized method, due to the 
different pulling strength of each investigator, not uniformly distributed over the hair bundle 
and variations of density or thickness of hair shafts. Mention should be made that on the 
day of shampooing, the pull test can be negative, as the telogen hairs have been rinsed away 
[37]. The pull test is currently performed in clinical practice, but it is useful only if the same 
 examiner  performs it in acute phase of hair loss in the more severe conditions for diagnosis and 
 therapeutic follow-up [37].
4.2. Hair part width assessment
Assessment of hair density is important in patients with active hair shading or thinned hair. Hair 
part width is a test used for the assessment of hair density in different areas of the scalp: frontal, 
vertex, occipital, etc. In a scalp area with normal density, the hair parting with a comb discovers 
a very fine and thin line, while an alopecia area has an irregular line with small clear areas on 
both sides of the part line (Figure 10). The dermatologist must take into consideration the fact 
that usually, the hair density on the vertex is lower and that thinning increases with age [51].
4.3. Counting hair tests
Literature reports that shedding over 100 hairs per day is abnormal, but for the patients 
with advanced stages (who already lost more than 50% of the hair), around 50% hairs/day 
Figure 10. Hair part width assessment in female patients: (a) healthy subject, without alopecia, (b) telogen effluvium 
subject, and (c) female pattern hair loss grade II on Ludwig scale.
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represents increased shedding. Usually when patients loose around 80–100 hairs/day they 
address the doctor’s office. The number of 100 hairs per day (in telogen phase, representing 
10% of hairs on the scalp, which could contain up to 100,000 hairs) is taken as an approximate 
value, it was not validated as a standard reference and it cannot be globally applied to all the 
patients suffering of alopecia [5, 11, 52].
The number of hairs shed can be misleading in women who do not comb their hair after 
shampooing and leave it to dry naturally, because when their hands ‘comb’ through the hair 
many loose hairs will appear on the fingers [5].
More refined ways of assessing hair loss were needed and dermatologists have developed the 
following counting hair tests:
Daily hair count is recommended to be performed by the patients who observe intense hair 
shedding on the brush, comb, pillow, floor, in the washing tub. The patient would collect all 
the hairs shed during a day and place them in a plastic bag, then handle it to the doctor [4, 5]. 
The test could provide inaccurate results because numerous hairs usually escape detection and 
it is disliked by the patients who complain that it is stressful and difficult to perform [2, 4, 5].
The 60 second hair count test consists of the following steps: using the same comb/brush 
for combing the hair for 60 seconds (over a sheet of contrasting color for easier collection 
of hairs) from the back top moving to the front of the scalp, repeating the procedure before 
three consecutive shampooings, counting of hairs from comb/brush plus sheet and recording 
the value. This procedure must be repeated monthly, for 6 months. The researchers applied 
this test to 60 men, not previously diagnosed with alopecia and concluded that the similarity 
between investigator and subject hair counts indicates a reliably hair count technique. The 
low intra patient variability proved dependable results over a longer period of time. The test 
seems a simple, practical and objective tool for monitoring conditions associated with hair 
shedding, but needs to be applied to FPHL patients as well [52].
For the standardized wash test patients have to restrain from shampooing for 5 days, then wash 
the hair in a basin with a gauze (covered drain) that allows the collection of the hairs (Figure 3). 
This non-invasive method involves the counting of hairs, but the results cannot be properly 
interpreted because a hair loss considered normal can range between 30–70 and 200–250 hairs on 
shampooing days [4, 37, 43]. The wash test is usually disliked by the patients because it involves 
a bad self-hygiene and unpleasant hair aspect that could interfere with daily activities [5, 11].
The daily hair count and standardized wash test were not practical methods for monitoring 
hair shedding, so improved tests were developed [52].
The modified wash-test was developed by Rebora et al. and involves the same technique:  washing 
the patient’s hair 5 days after the last shampoo in a sink with covered drain. The  collected hair 
is analyzed by the doctor and separated upon length: under 3 cm (belonging to short telogen 
vellus hairs), intermediate (between 3 and 5 cm) and long (above 5 cm). The test provides the 
total number of telogen hairs and the percentage of telogen vellus hairs and makes the difference 
between FPHL (with increased rate of vellus hairs, around 59%) and telogen effluvium (less than 
4%). The test is difficult to apply to patients with very short hair and curly hair [53].
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Both washing tests have the following disadvantages: unstandardized method with difficulties 
because of the shampoo, water, duration, strength of the massage and significantly time-consuming.
4.4. Common scales for staging of hair loss
Staging of hair loss patients is important in assessing the disease severity, to record the 
 progression of alopecia or determine the response to therapy. Various classification systems 
have been suggested from simple versions based on the recession of the hairline to advanced 
multifactorial ones, based on morphological and dynamic parameters that affect both the 
scalp and the hair [54]. Hamilton (1951)-Norwood (1975) classification for males and Ludwig 
(1997) scale for women are the most commonly used [12, 27, 55] (Figures 1 and 2).
An easy to memorize and novel classification for alopecia in both genders is the Basic 
and Specific classification (2007), which includes the shape of the anterior hairline (basic 
 classification with four types: L, M, C, U) and the hair density on distinct areas such as frontal 
and vertex (specific classification with two types F and V) [54].
The photographic assessment of hair loss severity developed by Sinclaire (2004) (scalp with 
hair parted in the center), was especially useful in chronic telogen effluvium [54] (Figure 3). 
Recently, Martínez-Velasco et al., issued the hair shedding visual scale, considered a fast and 
effective method of evaluating hair-shedding amounts in an office setting [41].
5. Photographs of the affected areas
Besides being present in the Sinclair scale (as a classification of the degree of hair loss severity), 
photographs are used for their general purpose, documentation of alopecia extent or evaluation 
of treatment efficacy (Figure 10).
Photographs should include both close-up views and global views to identify nearby landmarks. 
Four standard views (vertex, midline, frontal, temporal) should be captured with the same  camera, 
magnification and lighting conditions [56]. The Canfield technique is the most commonly used for 
alopecic patients and needs the following requirements to be fulfilled: little  extraneous information 
such as distracting clothes or backgrounds, a certain stereotactic position of the device and of the 
patient’s chin and forehead, the same hair preparation each time (the doctor or a technician should 
perform the same hair parting each time, comb the hair), and the hair should be clean and dry. Oily 
or wet scalps have increased reflection, revealing more skin than hair, giving the false impression 
of less hair. In order to record the patient’s cosmetic state at each follow-up visit it is recommended 
that the patient maintains the same hairstyle and hair color in order to decrease the variability of 
the technique and assure an easy assessment [5, 11]. The serial  photographic documentation of hair 
loss or hair regrowth represents an objective and  useful assessment method only if the doctor uses 
a regimented approach at each photographic session [56]. Up to the present, clinical researchers 
studying androgenetic alopecia used controlled photography to determine the efficacy of therapy, 
but this technique should be applied to various types of alopecia [5, 56].
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In spite of its advantages, the imaging tests do encounter some problems in female patients, 
who usually try to hide the hair loss condition by changing the hairstyle (cutting the hair 
shorter to let the impression of more volume) and the color (dying the hair into brighter 
shaded in order to give the impression of increased density and hide the alopecic areas) [5, 11]. 
Global photographs can be combined with other evaluation methods, such as: trichogram, 
phototrichogram, TrichoScan or hair weighting [26, 37, 50].
Recently, photography of alopecic scalps has overpassed its medical use and has become a form 
of art meant to raise awareness about alopecia areata, in a project by Sigriour Frimannsdottir 
called Baldwin (meaning strength).
6. Assessment of hair characteristics with different tests
6.1. Trichogram
The trichogram is used for hair root and hair cycle investigation. It is semi-invasive: 60–80 
hairs are plucked with a rubber-armed forceps in a quick pull perpendicular to the scalp, in 
the  direction of hair growth. Two areas of interest are investigated in AGA, diffuse  effluvium 
and loose anagen hair: the occipital area (2 cm lateral from protuberans occipitalis) and 
2 cm behind the frontal line and 2 cm from the midline respectively. In AA the  investigation 
focuses on the border of the alopecia patch and on the contralateral, unaffected side. After 
hair  collection, the bulbs are placed on a glass slide, in an embedded medium for later 
 examination. Hair roots are investigated under magnification lens or a low-power microscope 
and the number of hairs in each stage of the hair cycle is provided as percentage of the total 
number of plucked hairs [57]. Besides being laborious and time-consuming, the technique has 
another disadvantage: the superfluous remaining hair dyes in furrows mimic hair leading to 
false results [37].
6.2. Unit area trichogram
The unit area trichogram represents a semi-invasive quantitative method used until 
now in clinical trials to observe hair growth cycle and monitor different hair growth 
 therapies [57]. It focuses on the main growth parameters: hair follicle density, proportion 
of anagen fibers, hair shaft diameter. The investigated scalp area is degreased with an 
acetone:isopropanol (60:40) mixture to remove surface lipids and the hair is plucked from 
an area of more than 30 mm2 with a single smooth action in the direction of hair growth 
to minimize root trauma. The hairs are mounted on a double-sided tape and ordered by 
length. By microscopic analysis the investigator will establish the hair growth phase and 
measure the hair length, the major and minor axis of hair to determine the hair shaft 
 diameter. The disadvantages of the method are: patient discomfort, extended hair regrowth 
time until obtaining any test results, time consuming, unsuitable for a large number of 
patients [37, 57].
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6.3. The tug test
The tug test is performed when hair fragility and hair shaft abnormalities are suspected [5]. 
With the fingers of one hand, a section of hair is grasped, holding it near the root while the dis-
tal ends or hair tips are plucked (as plucking feathers) [6] (Figure 9). The dermatologist tugs 
to see if the strands break in the middle into small bits. If positive, the test gives  information 
about hair brittleness or fragility [3, 11].
The hair feathering test is usually performed in patients who complain that their hair does not 
grow or breaks off. The distal 2–3 cm of hairs are rubbed between the thumb and index finger, 
then a brisk pull is made on the ends of the hairs. A positive test would reveal short broken 
hair fragments on the examiner’s fingers [37]. The next step is the light microscopic inspection 
of the hair shaft to discover the underlying defect.
6.4. Hair mount
The short segments of hair shaft from the tug test are placed on a clean microscope slide. The 
examiner must place them parallel to each other. One or two drops of mounting medium such 
as Permount or similar, are used on slide and hair, then a cover slip is placed, avoiding the 
presence of air bubbles. The slide is then examined under a light microscope [6].
6.5. Microscopic evaluation
The following equipment is necessary when assessing the hair: a stereomicroscope with a 
magnification up to 100× (for the initial examination of mounted and unmounted hairs), 
a  high-quality transmitted light microscope (examine and identify the microscopical 
 characteristics of hairs in a range of 40–400×) or a high-quality transmitted light  comparison 
microscope (for comparing the microscopical characteristics of hairs). For comparison 
 microscopy it is desirable to have a second hair examiner verify the microscopical hair 
 association that may have probative value. Usually hair comparisons are conducted among 
hairs from the same somatic region, with hairs of similar length, each with a root present or in 
a similar growth phase as the questioned hair [58].
A polarized light microscope is helpful in order to examine certain features and to determine 
the cross-sectional shapes of the hairs.
The hair examiner should be familiar with the instruction manual, maintenance  requirements, 
performance and calibration checks and color balance. The hair sample may present  adhering 
material (if considered significant it should be removed and preserved for later analysis) which 
can be removed by washing or cleaning the hair, then allowing it to dry prior to  mounting [58].
Macroscopical and stereomicroscopical examinations enable the description of hair  characteristics 
(color, length, shape, texture, etc.) and the identification of hairs suitable for microscopic 
 comparison or the ones which have roots suitable for DNA analysis [11, 59]. Microscopical 
examination is helpful to complete the hair wash tests for hair cycle phase differentiation, shaft 
abnormalities and morphologic appearance of the distal tip [37] (Figure 11).
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Macroscopical examinations are useful for observing hair characteristics such as color (white, 
blonde, red, brown, black), hair shaft form (straight, arched, wavy, curly, twisted, tightly 
coiled, crimped), hair length (in cm) or hair shaft overall thickness (fine, medium, coarse).
Microscopic examination enables the observer to describe the color, natural pigmentation 
 (pigment size, pigment aggregation, aggregate size, pigment density, pigment distribution) or the 
color treatments performed, such as dyes (permanent, semipermanent, temporary), bleaches or 
lighters. Hair characteristics assessment performed by microscope include the shaft  description: 
diameter (in μm), cross-sectional shape (round, oval, triangular, flattened), shaft configurations 
(buckling, convoluting, shouldering, undulating, splitting, regular), medulla/cuticle/cortex 
 configurations, description of proximal ends with root present (telogen/catagen/anagen/sheathed/
follicular tag/ postmortem banding/putrid) or root absent (severed, decomposed, crushed), and 
description of distal ends (tapered or uncut tips, rounded or abraded, square cut, angular cut, 
frayed, split, crushed, broken or singed).
Acquired characteristics are also available for analysis and include: artifacts (nits or lice, old, 
fungal tunnels, insect bite marks, debris or blood), artificial treatments other than color (hair 
sprays, gels, permanents, cosmetics), environmental/chemical/mechanical damage markers and 
hair abnormalities (pili annulati, trichoschisis, monilethrix, trichorrhexis nodosa, trichorrhexis 
ingavinati, pili torti, trichonodosis, trichoptilosis) [58, 59].
In pili annulati the hair is stripped, with a pattern of light and dark banding. Trichoschisis 
represents a sudden shaft break across the diameter of the fiber with the localized absence 
of the cuticle at the site of fracture. In monilethrix, individual strains of hair have a “beaded 
appearance”, like the beads of a necklace, presenting a periodic narrowing of the hair shaft 
[47]. The abnormality in trichorrhexis nodosa is the formation of nodes along the shaft as a 
response to physical or chemical trauma [37]. Trichorrhexis invaginata (bamboo hair) is due 
to abnormal keratinization leading to weak hair shaft cortex at specific points along its length. 
In pili torti, hair has a flattened shaft with clusters of narrow twists at irregular intervals. 
Figure 11. Embedded hair roots under 10× magnification (optical digital microscopy Leica DMD108): (a) catagen hair in 
a female with telogen effluvium and (b) telogen hair in an AGA patient.
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Trichonodosis is characterized by knotted hair on the distal portion of the shaft, sometimes 
due to mechanical factors such as scratching or combing. In trichoptilosis, hairshafts become 
dry and exhibit splitting or fraying of the hair due to excessive exposure to chemical, thermal 
or hairdressing procedures [48]. If the hair shaft is apparently normal in microscopy, other 
tests can be performed, such as: KOH mount or root exam [59].
Besides the presence of the above mentioned genetic hair shaft abnormalities, the individual 
hairs in an affected area may be notably curly or kinky due to dermal fibrosis and subsequent 
follicular torsion [6].
Electron microscopy is distinguished by its high spatial resolution in the nanometer range, 
 compared to optical microscopy. Even though it reveals higher details, the pretreatment 
required of the hair is more extensive and usually leads to artifacts. Another type of  microscopy 
used for hair is atomic force microscopy (AFM), which uses the principles of scanning  tunneling 
microscope and the stylus profilometer in order to provide 3D images with high resolution at 
the nanometer scale, together with qualitative and quantitative measurements of the sample 
[37]. AFM is limited to the measurement of the topographic morphology perpendicular to the 
sample plane (re-entrant surfaces and surface information cannot be detected), so it is not used 
in clinical practice.
6.6. The contrasting felt examination (hair card test)
The purpose of this test is to evaluate the number of new hair strands that are growing and 
to examine the health of the hair shafts. Good lighting is essential. The dermatologist creates 
a part in the hair and uses a small rectangular index card with black felt glue on one side 
and white felt on the opposite side [5, 11]. The hair card is placed as close to the skin surface 
as possible and is used on the scalp, brows, eyelashes, etc. Hairs shaft and tips will be held 
by the doctor against the contrasting black or white background, depending on the color of 
the hair, for maximal contrast (if dark hair is examined, use the white side) (Figure 12). New 
hair strands, fine short miniature or broken hairs will project up along the edges of the felt 
card, so that they can be counted and examined [5]. If the distal ends are tapered or pointed 
(like the ends of the eyelashes) they indicate new hairgrown [6]. If the distal ends are blunt 
or straight, they may have been broken or cut. If some of the new short hair is thinner in 
diameter than the rest, it indicates miniaturization [6]. The test is useful in the recognition 
of very thin strands in telogen effluvium, short vellus hairs (with miniaturization) in AGA 
and FPHL patients or short strands with broken tips in hair shaft abnormality disorders.
The hair card has a ruler portion which can be used for measuring: the length of new growth, 
the dimension of hair loss area or the temporal recession [6] (Figure 12). Using the ruler side 
of the hair card, one can measure the distance from the lateral end of the brow to the apex of 
the temporal recession (in males the normal distance would be 6–6.5 cm) [6].
6.7. Hair weight determination
Hair weight determination involves the selection of a scalp area (usually an area of 1.34 cm2 in 
the frontoparietal region), where the hair is clipped under magnification to a length of 1 mm at 
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baseline, the scalp is permanently marked by tattoos, the hair is allowed to grow for a period of 
time (from 4 to 24 months, depending on the treatment performed), then clipped again, collected 
carefully and weighed by an experienced technician [5, 11]. The method is a quantitative one, but 
unfortunately it is not standardized and precise. It has been used in clinical trials, but was not 
applied in clinical practice due to its demerits: time consuming, no immediate results are available, 
no specific scalp areas to be assessed, improper capturing of the hairs, frequent mistakes during 
the clipping process, incomplete trimming of hairs from that area, unspecified time for regrowth 
[4, 49]. Also, the method has been rejected by the patients, especially female patients who do not 
agree to have the hairs clipped/cut from visible scalp areas, such as the frontal area [5].
6.8. Hair densitometry
This determination was classically performed since 1993 with a densitometer: a handheld 
magnification lens device with an opening of 10 mm2, used to check for miniaturization of 
the hair shaft, to describe the follicular unit composition and to assess the hair density [50]. 
First, the doctor clips the hair, about 1 mm short, and the instrument is then placed on the 
scalp. Then the total number of hairs in the field are count, the number of hairs per follicular 
unit is assessed, as well as the diameter of the hair, looking in particular for abnormal levels 
of miniaturization (decreased hair shaft diameter) [5].
In practice, hair densitometry is used to evaluate a patient’s candidacy for hair transplantation, 
as it assesses a person’s donor hair supply and anticipates the esthetic outcome of the hair 
restoration procedure [50]. Otherwise, the method is extremely laborious and tiring, less 
 accurate than computed hair analysis.
A modern version for determining hair densitometry is the HairCheck device (Divi International 
Co., Miami), a cross-section trichometer. This quantitative method enables a precise evaluation, 
since it indirectly measures the density (n/cm2) and diameter (μm) of hairs by directly deter-
mining the cross-sectional area of all the hairs in a premeasured area of scalp skin [50]. The 
measurements are performed without cutting the hair, by using an inked four legged device 
and selecting an area of 4 cm2. The hair from that area is gathered with a pinhead tool, then 
Figure 12. (a) Measurement of AA single patch dimensions using a ruler and (b) the hair card test performed on a telogen 
effluvium female patient.
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clipped between fingertips and introduced as a bundle in the J type hook of the measuring 
device [4, 60]. The HairCheck tool produces a compression of the hair bundle which is engi-
neered to deliver the same predetermined load and the force without damaging the captured 
hair [60]. On a LED display appears the trichometric index, which represents the height of the 
compact bundle in its capture chamber, with a value between 75 and 100, expressed as square 
millimeters of hair per square centimeter of skin × 100 (mm2/cm2×100). Several tests done by 
Cohen have proved its accuracy and concluded that there was a direct correlation between 
the bundle’s cross-sectional area and the number of surgical silk fibers/filaments, the diameter 
of the filaments and their dry weight [60, 61]. The HairCheck method is used to quantify by 
comparison the amount of hair lost or gained and it is extremely helpful as it offers regrowth 
information by direct assessment of the hair mass (on density and diameter changes) [4]. In one 
personal study on FPHL, we have successfully used the HairCheck assessment on monitoring 
the patients’ evolution under treatment [5, 11] (Figure 13).
The HairCheck device offers also the possibility to determine the hair breakage index (HBI) or 
percentage of broken hairs, which is performed with a proximal and a distal HMI measurement 
on the same isolated bundle (Figure 14).
Figure 13. Hair density measurement also known as hair mass index (HMI) with the HairCheck device: (a) pinhead tool 
(area for measurement), a template with inkpad to demarcate a pre-measured site, calibration tool; (b) a locating strip 
attached to glasses; and (c) the determination of hair mass by compressing the hair bundle in the J hook of the device.
Figure 14. Hair breakeage index (HBI) measured with the HairCheck device (a) at proximal part of the hair bundle and 
(b) at the distal part of the hair bundle (tip of hair stand).
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6.9. Computed hair analysis
Conventional approach to evaluate an alopecic patient implies visual evaluation, which 
may hinder an objective assessment. For this reason, several researchers tried to develop a 
quantitative method using a computer-aided imaging system. A study has used a series of 
digital image processing techniques to measure the width of central balding area of FPHL: 
the balding area was identified by the computer, which measured the ellipse of balding [26]. 
The values obtained were significantly correlated with the Savin clinical scale.
A reliable computer-aided imaging system besides staging the severity of the alopecia, could 
also monitor hair loss and treatment responses.
TrichoScan is a new device, based on epiluminescence microscopy, combined with automatic 
digital image analysis for the measurement of human hair, focusing of the following 4 parameters: 
hair density (number per cm2), hair diameter (μm), hair growth rate (mm per day), and anagen/
telogen ratio [54]. The investigator chooses and clips an area of hair loss between normal hair 
and the balding region. Images are obtained by pressing onto the scalp a digital camera with 
rigid “contact lens” (so they are taken at the same distance from the scalp) fitted with a close-up 
microscopy attachment [37].
TrichoScan represents an automated image analysis tool that can determine the surface, 
 miniaturized hair density, terminal hair density, percentage of terminal and miniaturized 
hair, anagen and telogen percentage. The device is precise and has an intraclass correlation 
of approximately 97% for different TrichoScan operators. The advantages of the TrichoScan 
examination make it a useful tool to assess placebo versus treatment, to compare  different 
capacities of hair growth promoting substances, to study AGA and diffuse hair loss, to 
 evaluate the effects of drugs and laser treatment on hypertrichosis and hirsutism [62]. One 
disadvantage consists of the fact that gray or fair colors have limited contrast with light scalp 
skin and need to be dyed for 15 min with a solution provided with TrichoScan, that needs to 
be mixed 1:1 with development cream.
Literature reports underline that computer-aided imaging systems are valuable methods of 
quantifying hair loss, than can assist the physicians in evaluating the balding area more precisely 
for clinical staging.
6.10. Optical coherence tomography
Optical coherence tomography is used for measuring hair shaft longitudinal and  transverse 
diameters, cross-section-surface area and hair shape, similar to histology, but in vivo. This 
procedure uses low-coherence interferometry to produce a two-dimensional image of 
optical scattering from internal tissue microstructures analogous to ultrasonic pulse-echo 
image, which works with ultrasound. The results consist of a running time of a  near-infrared 
signal to a studied specimen and back, that will be compared to a known reference 
signal [37].
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6.11. Hair analysis methods
Hair analysis methods are used for the evaluation of genetic disorders, the investigation of 
physicochemicals properties of hair in disease, the study of exposure to certain substances, 
etc. Plucked hairs from the temporal area are preferred. The hair should be uncontaminated: 
a non-exposed part of a growing anagen hair fiber or close to the infundibulum of the hair 
follicle. The sample of hair is cleaned and put through a number of spectrographic processes 
capable of identifying as many as 40 trace elements [37].
6.12. Mechanical tests of hair quality (elasticity, strength, fragility)
The evaluation tools for the physical properties of hair focus on the integrity of the internal 
structure of the fiber and its alteration due to environment, cosmetics or treatments applied. 
The measurements of mechanical properties are easy to perform and the most common is 
the tensile property test, which focuses on the stress/strain curve of single hair fibers and is 
measured with an extensometer. The hair is fixed between two ferrules in a sample cassette 
of the instrument and a constant speed of extension is exerted until the hair fiber breaks [37].
7. Scalp biopsy
A scalp biopsy is recommended to be taken as soon as the dermatologist suspects cicatricial 
alopecia [5].
7.1. Scalp biopsy technique and requirements
There are some requirements for the patient, such as refraining from topical steroids usage 
(Clobetasol, Betamethasone, Fluocinonide, Clobex, Luxiq, etc.) for 1 week prior to the biopsy. 
On the day of the biopsy the hair should be washed and without any hairspray, gel, mousse 
or topical camouflaging fibers and agents (Toppik, DermMatch, Couvre, etc.) [21]. Certain 
lifestyle choices (smoking, excessive drinking) increase the risk of side effects such as bleeding 
and slow healing [11]. The best position for scalp biopsy harvesting is with the patient sitting 
down on a chair, leaning over the examination table, bracing their head with their hands, also 
known as “the Thinker position” [5]. For a biopsy from the occipital scalp, the patient may lie 
on the examination table facedown or sit on a chair and rest his head down on the evaluation 
table, “taking a nap on the school desk position” (Figure 15).
The doctor should select an active hair-bearing area with an advanced thinning and a preferred 
positive anagen pull test (more than six hair fall), clean the area and disinfect it with alcohol, 
iodine or similar solution, sometimes trim a few hairs from the area [9, 21]. Some dermatolo-
gists select an area with active inflammatory disease (early thinning with visible erythema 
and mild scaling), an incipient one, not with end-stage changes of scarring [63]. This type of 
area is preferable in cicatricial alopecia, in which it is highly recommended to take the biopsy 
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at the periphery where compounding is not present. Taking biopsy specimens of tuft of hairs 
(polytrichia or compounding follicles) is not helpful as these nonspecific structures are end-
stage features of many cicatricial alopecias, including lichen planopilaris, central centrifugal 
cicatricial alopecia, also lupus [63].
Local anesthesia is usually performed with 1% lidocaine with epinephrine and the wait time 
should be 10 min for a maximum vasoconstriction. Hemostasis can be performed with the 
help of an assistant using gauze squares and Q-tip [5]. Scalp samples can be obtained either by 
classic surgical collection in an elliptical incision of the skin or by punch biopsy [9]. The most 
 common method is by using a 4 mm-punch biopsy (12.6 mm2) for vertical sectioning or horizontal 
 sectioning [55]. The punch tool is placed on top of the scalp, pressure is applied until the  doctor 
samples down to subcutis and with the help of the needle the excised skin is removed [11]. Some 
dermatologists consider that both vertical and transverse sections of scalp biopsy specimens are 
needed. Transverse sections seem to provide a better assessment of the histological features than 
vertical sections in specimens provided by alopecia areata patients [64]. On the other hand, some 
dermatopathologists strongly prefer vertical sections, especially in cicatricial alopecias, as they 
allow the assessment of alopecias associated with interface changes, lichenoid infiltrates and 
subcutaneous pathology [63]. The vertical sectioning biopsy technique represents a qualitative 
approach, including just 10% of the hair follicles, and being susceptible to sampling errors. On 
the other hand, the transverse section is a quantitative approach providing all the hair follicles 
present in the biopsy, offering data of follicular cycling, as well as morphometric evaluation of the 
hair follicles throughout their entire length. The transverse biopsy enables the detection of even 
focal pathology and is preferred in most of the cases of nonscarring alopecia, because of the larger 
number of follicular structures that can be studied [55].
The dermatologist can close the defect with suture with classic stitches (which should be 
removed in 10–14 days) or dissolving stitches (which dissolve fully in 6–8 weeks) [11]. In case of 
punch biopsy, a single stich is common or some dermatologists leave the wound open [9]. The 
Figure 15. Positioning of the patient for scalp biopsies and injections: (a) sitting on a stool, leaning over the exam table, 
bracing their forehead “the Thinker position” and (b) patient lying on the examination table facedown.
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next day after the biopsy the washing and shampoo is allowed, usual product used on scalp can 
be used the day after, while dying and coloring of hair is permitted 1 week after the biopsy [63].
7.2. Scalp biopsy results
Besides sending the biopsy specimen to the dermatopathologist, the dermatologist must provide 
the patient characteristics (age, race), duration of condition and clinical pattern, and sometimes 
a photograph is helpful, if available. There are differences in normal hair densities depending 
on race, also certain racial groups have higher predilections for some diseases [63, 65].
If the biopsy provides a diagnostic, it can offer information about a systemic disease (discoid 
lupus erythematosus, sarcoidosis, lichen planus follicularis, necrobiosis lipoidica diabeticorum, 
etc.), an infection (fungal, bacterial, protozoan) or even a neoplasm (basal cell carcinoma in 
the morpheaform, squamous cell carcinoma, metastatic carcinoma in the alopecia neoplastica 
form, lymphoma or adnexal tumors, etc.). If the biopsy is not diagnostic, the dermatologist 
should suspect a hereditary disorder or trauma/injury (mechanical trauma, burn, caustic 
agent, exposure to radiation, etc.) [64].
In AGA, the biopsy sample contains increased number of miniaturized hairs, abundant 
enlarged sebaceous glands and minimal inflammation. A ratio of terminal (T) to vellus (v) 
ratio 3:1 or less is considered to be diagnostic [63, 64, 65].
Patchy and diffuse alopecia areata present peribulbar lymphocytic infiltrate around anagen 
hair bulbs, rich in helper T cells, evidence of an autoimmune process. Alopecia areata should be 
suspected when high percentages of telogen hairs are present, even if the peribulbar  infiltrate 
is not present. Both types of AA may sometimes coexist with Androgenetic alopecia [5, 9, 64].
Histologically in LPP the pathologist can find two patterns: hair follicles and the perifollicular der-
mis mainly involved in the pathologic process (with no involvement of the  interfollicular struc-
tures) or the pathologic changes extended to the interfollicular epidermis and  papillary  dermis 
[55]. Direct immunofluorescence shows the presence of colloid bodies in the  peri-infundibular 
area staining with IgM, while the immunohistochemistry staining shows a significant alteration 
in the basement membrane structure, which differentiates it from active DLE lesions [66].
The distinctive clinical features of DLE of the scalp are the presence of erythema, scaling, 
 telangiectasia, mottled hyperpigmentation within the areas of scarring alopecia and the 
 presence of hyperkeratotic papules in the central part of the bald area in DLE, while in LPP 
it is present at the margin of the alopecia patch [67]. When routine histological findings are 
 equivocal, direct immunofluorescence (DIF) helps, but light microscopy should be performed 
before DIF. The suggestive findings are: multiple immunoreactants deposits around hair 
 follicles (not seen in other scarring alopecias) typically IgG and IgM, in a special pattern (bright 
in intensity, continuous, perifollicular, and granular) [67].
7.3. Scalp biopsy complications
Patients should be aware that a small scar will be present permanently in the area where the 
biopsy was taken, resulting in a new area with no hair regrowth [9, 19].
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As with any medical procedure, there are some possible preoperative, intraoperative and 
postoperative risks [68]. Preoperative risks can be related to the used anesthetic. Performing 
of a patch test is recommended if true sensitivity to the anesthesia is suspected, in order 
to avoid an anaphylaxis, situation which rarely occurs. History of syncopal attacks are 
 important, as a vasovagal attack can be present in this clinical setting [68]. Intraoperative 
risks involve  bleeding, difficulty in closing the skin defect, pain and discomfort caused by 
insufficient anesthesia [68].
Postoperative risks such as pain, discomfort, bleeding, swelling, tenderness develops, and 
some of the symptoms can be relieved by medication, prescribed by the dermatologist. Besides 
scarring and hyperpigmentation, postoperative infection develops in 22% of the cases, but it 
can be easily treated with antibiotic. Another possible complication consists of temporary 
numbness or weakness, due to nearby nerve structures damage, which usually represents a 
nonpermanent situation [68].
8. Laboratory investigations
There are no laboratory tests indicated in AGA male patients who are using topical minoxidil 
or finasteride [3].
Extensive hormonal testing is not required in female patients, unless symptoms and signs 
of androgen excess are present (hirsutism, acne, virilization, etc.). The female patients 
who require endocrine evaluation are identified with careful inquiry regarding: menstrual 
irregularity, history of infertility, galactorrhea, etc. If positive, laboratory measurement 
of the following hormones is necessary, in order for the dermatologist to have a clinical 
evidence of the androgen excess: serum total testosterone, free testosterone, dehydroepi-
androsterone sulfate (DHEA-s) and prolactin levels [3, 34]. All the above plus the follicle 
stimulation hormone (FSH) and luteinizing hormone (LH) are recommended to be per-
formed in FPHL. Habif recommends that testosterone-estradiol–binding globulin (TeBG) 
should be also tested, in order to obtain the level for the total testosterone/TeBG ratio [17, 
26]. If elevated, this androgenic index may indicate a pituitary disease (e.g., pituitary pro-
lactinoma 8).
Tosti considers that 30% of all hair loss is caused by polycystic ovary syndrome PCOS and for 
diagnostic a pelvic ultrasonography is required [3].
Every patient with hair loss should have the following baseline studies: complete blood 
count (CBC) and iron study including serum iron and ferritin to rule out iron deficiency 
[12]. Also, thyroid function tests (free T3, free T4 and TSH) and serum thyroid autoanti-
body (anti-TG and anti-TPO levels) need to be done to rule out a possible thyroid disease, 
especially in telogen effluvium [3, 53, 60]. Estimation of blood cadmium (Cd) levels may be 
important in cases of chronic telogen effluvium as its toxicity can be an underlying hidden 
cause [69].
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Other common causes of hair loss investigated by measurement of different serum levels: 
serum thyrotropin and vitamin D 25OH (deficient serum levels of the vitamin are present in 
AA patients and inversely correlate with disease severity) [70]. In AA it is also recommended 
to test: erythrocyte sedimentation rate (ESR) and rheumatoid factor (RF).
In order not to miss other possible factors, antinuclear antibodies (ANA) test is performed for 
the diagnostic of systemic lupus erythematosus. Reagin plasma response (RPR or VDRL) test 
is necessary to rule out syphilis.
In tinea capitis, the following tests are recommended: culture swab, potassium hydroxide 
(KOH) examination and fluorescence examination with Wood’s lamp. In dissecting cellulitis 
of the scalp discharge is common and should be cultured [12, 60].
If all the laboratory results are normal, the dermatologist can consider:
• Other nutritional deficiency (malnutrition, sprue, zinc deficiency)
• Trauma (Trichotillomania, traction alopecia)
• Hereditary syndromes [8, 57]
Laboratory investigations are not only used as diagnosis tools, but are also necessary in the 
treatment initialization or evaluation. Systemic medication that inhibits androgen production 
or its effects (spironolactone, cyproterone acetate, flutamide) represents a second-line treatment 
in FPHL. For safety purposes, women taking spironolactone should have potassium levels 
checked prior to therapy [3, 12]. Women taking antiandrogens or oral contraceptives at 
3–4 months after the onset of therapy must have the levels of free testosterone and dehydro-
epiandrosterone (DHEA)-sulfate measured [13, 14].
9. Conclusion
Although dermatologists have a large number of evaluation methods for hair loss and hair 
regrowth, most of them are not standardized and their applicability is limited in clinical 
setting. The majority of these evaluation methods are rejected by the patients because they 
are too invasive, time consuming and difficult to perform or involve a bad hygiene and hair 
aspect that interferes with daily activities. Taking into consideration all these problems that 
occur in clinical practice we underline the necessity of more refined and precise evaluation 
tools for assessing hair loss patients.
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